Published in Gut on March 01, 2005
Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst (2015) 2.94
Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data. J Clin Oncol (2011) 2.43
Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol (2008) 2.43
Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer (2010) 2.34
Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Ann Surg Oncol (2014) 1.48
Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One (2012) 1.35
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis (2011) 1.33
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer (2007) 1.23
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl) (2008) 1.16
Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J Gastroenterol (2006) 1.15
Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate. Br J Cancer (2008) 1.13
Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer. Br J Cancer (2014) 1.10
HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling. Mol Cancer (2010) 1.08
Differences in survival between colon and rectal cancer from SEER data. PLoS One (2013) 1.06
Gene expression differences between colon and rectum tumors. Clin Cancer Res (2011) 1.03
Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups. Br J Cancer (2007) 1.02
The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol (2008) 1.02
Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples. PLoS One (2012) 1.01
Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One (2013) 1.01
Using rule-based machine learning for candidate disease gene prioritization and sample classification of cancer gene expression data. PLoS One (2012) 1.00
Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis. Mol Med (2011) 1.00
Diarrhea as a cause of mortality in a mouse model of infectious colitis. Genome Biol (2008) 0.99
Expression and prognostic value of transcription factor PROX1 in colorectal cancer. Br J Cancer (2011) 0.96
Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer. Cancer Res Treat (2010) 0.93
Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon. Am J Physiol Gastrointest Liver Physiol (2014) 0.92
The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells. Cancer Biol Ther (2010) 0.92
The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers. J Gastrointest Oncol (2013) 0.91
A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation. Oncogene (2011) 0.91
Clinical applications of gene expression in colorectal cancer. J Gastrointest Oncol (2013) 0.91
A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study. Carcinogenesis (2014) 0.89
Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer. Gut Liver (2013) 0.88
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma. BMC Clin Pathol (2012) 0.86
Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers. World J Gastroenterol (2008) 0.86
Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice. J Clin Invest (2009) 0.85
Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma. BMC Cancer (2015) 0.84
Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer. BMC Cancer (2014) 0.83
Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study. Dig Dis Sci (2016) 0.82
hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features. Int J Colorectal Dis (2008) 0.82
Increased expression of cellular repressor of E1A-stimulated gene (CREG) in gastric cancer patients: a mechanism of proliferation and metastasis in cancer. Dig Dis Sci (2010) 0.81
Cdx1 and Cdx2 exhibit transcriptional specificity in the intestine. PLoS One (2013) 0.81
Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells. Chem Res Toxicol (2006) 0.81
mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray. World J Gastroenterol (2006) 0.81
Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study. Int J Colorectal Dis (2012) 0.80
Membrane protein profiling of human colon reveals distinct regional differences. Mol Cell Proteomics (2014) 0.79
A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites. Int J Colorectal Dis (2015) 0.79
Trends in colorectal cancer among hispanics by stage and subsite location: 1989-2006. Clin Transl Gastroenterol (2012) 0.79
KRAS mutation profile differences between rectosigmoid localized adenocarcinomas and colon adenocarcinomas. J Gastrointest Oncol (2014) 0.78
Copy number alterations and allelic ratio in relation to recurrence of rectal cancer. BMC Genomics (2015) 0.77
Roles of Sulfur Metabolism and Rhodanese in Detoxification and Anti-Oxidative Stress Functions in the Liver: Responses to Radiation Exposure. Med Sci Monit (2015) 0.77
Absence of keratins 8 and 18 in rodent epithelial cell lines associates with keratin gene mutation and DNA methylation: Cell line selective effects on cell invasion. Exp Cell Res (2015) 0.77
Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location. J Natl Compr Canc Netw (2016) 0.77
Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1. Cancer Prev Res (Phila) (2016) 0.76
Differential expression of carbohydrate antigen 19-9 in human colorectal cancer: A comparison with colon and rectal cancers. Mol Clin Oncol (2013) 0.76
Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients. J Transl Med (2016) 0.76
Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis. Yonsei Med J (2015) 0.76
S100P, a calcium-binding protein, is preferentially associated with the growth of polypoid tumors in colorectal cancer. Int J Mol Med (2015) 0.76
Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas. World J Gastroenterol (2016) 0.76
Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case-control study. Br J Cancer (2016) 0.76
Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia. Epigenetics (2014) 0.76
Molecular Mechanism for Various Pharmacological Activities of NSAIDS. Pharmaceuticals (Basel) (2010) 0.75
Adjuvant chemotherapy for rectal cancer: Is it needed? World J Clin Oncol (2015) 0.75
Aspirin, salicylates and cancer: report of a meeting at the Royal Society of Medicine, London, 23 November 2010. Ecancermedicalscience (2011) 0.75
Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification. Biomicrofluidics (2016) 0.75
Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients. BMC Cancer (2017) 0.75
Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer. Br J Cancer (2017) 0.75
Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A (1999) 35.16
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
A novel ras-related gene family. Cell (1985) 5.81
Are there two sides to colorectal cancer? Int J Cancer (2002) 5.18
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet (2000) 5.04
Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res (2001) 4.50
Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med (1996) 2.42
Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev (2003) 2.22
Gene expression in colorectal cancer. Cancer Res (2002) 1.98
Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut (1999) 1.84
Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol (2001) 1.83
Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis. Matrix Biol (2001) 1.71
Are right- and left-sided colon neoplasms distinct tumors? Dig Dis (1997) 1.70
Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J Biol Chem (2001) 1.40
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci (2002) 1.26
Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. Clin Cancer Res (1998) 1.15
No difference in stem cell somatic mutation between the background mucosa of right- and left-sided sporadic colorectal carcinomas. J Pathol (1998) 0.98
[Special aspects of right colon cancer]. Langenbecks Arch Chir (1987) 0.97
Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy. Clin Colorectal Cancer (2004) 0.97
Different expression of some molecular markers in sporadic cancer of the left and right colon. Eur J Cancer Prev (2000) 0.93
Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis (1999) 0.91
Transcript levels of aquaporin 1 and carbonic anhydrase IV as predictive indicators for prognosis of renal cell carcinoma patients after nephrectomy. Int J Cancer (1998) 0.91
Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166. Cancer Lett (2002) 0.90
The clinicopathological characteristics and outcome of patients with right colon cancer. Oncol Rep (1998) 0.85
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41
Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS (1988) 8.10
Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science (1998) 7.08
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93
Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet (1997) 4.27
Genetic mapping of a locus predisposing to human colorectal cancer. Science (1993) 4.12
Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol (2000) 3.98
Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31
Randomized clinical trial of laparoscopic versus open appendicectomy. Br J Surg (2001) 3.20
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology (2000) 3.01
Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer (1995) 2.85
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell (1999) 2.71
Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology (1996) 2.60
Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg (2003) 2.54
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res (1993) 2.48
Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med (1995) 2.40
Current management of locally recurrent rectal cancer. Colorectal Dis (2009) 2.31
Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res (2001) 2.12
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10
Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet (1994) 2.08
Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res (2001) 1.93
Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin Chem (2000) 1.85
MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer (1997) 1.83
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene (2000) 1.83
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet (2001) 1.81
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet (1999) 1.79
LKB1 somatic mutations in sporadic tumors. Am J Pathol (1999) 1.79
Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res (1996) 1.77
Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res (1998) 1.75
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res (2001) 1.74
Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg (2009) 1.71
Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes. Leuk Lymphoma (2007) 1.67
Diagnostic cancer genome sequencing and the contribution of germline variants. Science (2013) 1.65
Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci U S A (2000) 1.63
Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology (2003) 1.63
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet (2005) 1.61
The prognostic relevance of estimates of proliferative activity in early breast cancer. Histopathology (2003) 1.58
Self-expanding metallic stents as bridge to surgery in obstructing colorectal cancer. Br J Surg (2011) 1.56
LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.56
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene (2009) 1.56
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet (1999) 1.56
Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg (2012) 1.56
Malone antegrade continence enema for faecal incontinence and constipation in adults. Br J Surg (1998) 1.51
Colorectal adenoma and cancer divergence. Evidence of multilineage progression. Am J Pathol (1999) 1.50
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res (1997) 1.49
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Res (1997) 1.47
Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol (2001) 1.46
Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement. Colorectal Dis (2015) 1.45
The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology (1999) 1.43
Effect of darbepoetin alfa on physical function in patients undergoing surgery for colorectal cancer. A randomized, double-blind, placebo-controlled study. Oncology (2007) 1.43
Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene (2006) 1.43
Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett (2000) 1.42
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol (1996) 1.42
Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer (2005) 1.40
Suboptimal outcome following sacral nerve stimulation for faecal incontinence. Br J Surg (2010) 1.40
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer (2009) 1.40
Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Dis (2006) 1.39
Growth hormone treatment improves body fluid distribution in patients undergoing elective abdominal surgery. Clin Endocrinol (Oxf) (1998) 1.39
Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. Am J Pathol (1999) 1.38
[Urinary incontinence--not the same we are talking about]. Ugeskr Laeger (1998) 1.38
Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells. Diabetologia (2008) 1.34
The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. J Med Genet (2005) 1.34
Anorectal physiology validated: a repeatability study of the motor and sensory tests of anorectal function. Br J Surg (1989) 1.33
Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem (1999) 1.33
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33
Somatic microsatellite mutations as molecular tumor clocks. Nat Med (1996) 1.31
Screening for microsatellite instability target genes in colorectal cancers. J Med Genet (2002) 1.29
Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res (1996) 1.29
Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc Natl Acad Sci U S A (1999) 1.28
High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections. J Clin Microbiol (2000) 1.28
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24
Colorectal function in patients with spinal cord lesions. Dis Colon Rectum (1997) 1.23
Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg (1999) 1.22
Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut (2002) 1.22
Extensive somatic microsatellite mutations in normal human tissue. Cancer Res (2001) 1.22
Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology (2004) 1.21
Extracolonic findings at computed tomography colonography are a challenge. Gut (2003) 1.20
Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res (2001) 1.20
Associational and commissural collaterals of neurons in the hippocampal formation (hilus fasciae dentatae and subfield CA3). Brain Res (1981) 1.20
Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer. Br J Surg (2008) 1.18
Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut (2002) 1.18
Neurogenic bowel dysfunction score. Spinal Cord (2005) 1.18
Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet (1994) 1.18
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer (2005) 1.17
Risks of anal incontinence from subsequent vaginal delivery after a complete obstetric anal sphincter tear. Br J Obstet Gynaecol (1992) 1.17